X0508 4 2024-02-27 false 0001645113 NovoCure Ltd NVCR 0002001639 Giladi Moshe C/O NOVOCURE INC. 1550 LIBERTY RIDGE DRIVE, SUITE 115 WAYNE PA 19087 false true false false Chief Science Officer false Ordinary Shares 2024-02-27 4 A false 51124.00 16.30 A 69771.00 D Stock Options (Right to buy) 16.30 2024-02-27 4 A false 78174.00 16.30 A 2025-02-27 2034-02-26 Ordinary Shares 78174.00 78174.00 D Represents restricted share units that are scheduled to vest in equal installments on February 27, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates. Options to buy 78,174 ordinary shares will vest in equal installments on each of February 27, 2025, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates. Steven Robbins, as attorney in fact for Giladi, Moshe 2024-02-29